ESR1 and breast carcinoma: Interestingly, coumarin-based selective estrogen receptor modulators (SERMs) with high affinity for estrogen receptor (ER) were synthesized and used to block osteoclastogenesis [40] and to act as an antiestrogen on breast cancer cells [41].